Ironwood Pharma (IRWD) Misses Q4 EPS by 2c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $107.2 million versus the consensus estimate of $114.93 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• Ryman Hospitality closes $1.38B Grande Lakes Orlando deal